Seeking Alpha

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript

Ladies and gentlemen, thank you for standing by. Welcome to Pyxis Oncology MICVO Clinical Update Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...
BioSpace

Subcutaneous RYBREVANT® (amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and ...

New findings from this investigational study build on the strength of the data for amivantamab in non-small cell lung cancer and broadens its potential across additional solid tumours 1,2 “Patients ...
Frontiers

Comparison of PD-L1 expression in head and neck squamous cell carcinoma among preoperative biopsy, surgical resection and metastatic lymph node

1 Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea 2 Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The ...
Targeted Oncology

Novel ADC Earns FDA Fast Track in Head and Neck Cancer

CRB-701 targets Nectin-4 and has shown promising antitumor responses in a phase 1/2 study, with a 40% overall response rate at higher doses. The FDA fast track designation allows for expedited ...
Cure Today

FDA Grants Designation to Investigational Drug for Head and Neck Cancer

CRB-701 targets Nectin-4, delivering chemotherapy directly to cancer cells, minimizing damage to healthy tissue. The FDA's fast track designation aims to expedite CRB-701's development for HNSCC and ...
Medscape

Almost Half of Head and Neck Cancer Trials Go Unpublished

Nearly half (45%) of head and neck cancer clinical trials registered from 2005 to 2021 were never published. Trials without statistically significant results and those that were considered incomplete ...
WebMD

Metastatic Throat Cancer: What Happens When Throat Cancer Spreads?

What Is Metastatic Throat Cancer? It’s cancer that starts in your throat and spreads to other parts of your body. Your doctor may call it stage IV or advanced throat cancer. Most throat cancers are ...
Targeted Oncology

Immunotherapy Inches Forward in Head and Neck Cancer Trials

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly delineated, even in phase 3 trials. Although immunotherapy has emerged as an ...
Everyday Health

Head and Neck Cancer Signs and Symptoms

Head and neck cancers affect the tissues of the mouth, throat, sinuses, and surrounding areas. They can impact crucial functions like breathing, swallowing, and talking. There are several types of ...
Cancer Research

Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcome

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Nasdaq

Pyxis Oncology Announces Fast Track Designation from FDA for PYX-201 in Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Pyxis Oncology, Inc. announced that the FDA has granted Fast Track Designation for its drug PYX-201, aimed at treating adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...